RAC 2.80% $1.57 race oncology ltd

There is nothing fundamentally wrong with MST Access’s report,...

  1. 2,528 Posts.
    lightbulb Created with Sketch. 9519
    There is nothing fundamentally wrong with MST Access’s report, it is just very, very conservative in how it values Bisantrene and the FTO opportunity in particular. It is a great place to start any research, but I you really need to do your own research.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.57
Change
-0.045(2.80%)
Mkt cap ! $260.3M
Open High Low Value Volume
$1.60 $1.60 $1.55 $94.33K 60.12K

Buyers (Bids)

No. Vol. Price($)
1 1250 $1.57
 

Sellers (Offers)

Price($) Vol. No.
$1.59 5000 1
View Market Depth
Last trade - 14.37pm 16/05/2024 (20 minute delay) ?
Last
$1.56
  Change
-0.045 ( 1.17 %)
Open High Low Volume
$1.58 $1.59 $1.55 8174
Last updated 14.21pm 16/05/2024 ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.